Stockscreener 앱 받기
12.91
1.25%
0.16
시간 외 거래:
12.92
0.010
+0.08%
전일 마감가:
$12.75
열려 있는:
$12.7
하루 거래량:
251.50K
Relative Volume:
0.35
시가총액:
$218.91M
수익:
$53.74M
순이익/손실:
$33.24M
주가수익비율:
4.8476
EPS:
2.6632
순현금흐름:
$-27.40M
1주 성능:
+0.31%
1개월 성능:
+104.92%
6개월 성능:
+348.26%
1년 성능:
+696.91%
1일 변동 폭
$12.67
$13.40
1주일 범위
$11.97
$13.71
52주 변동 폭
$1.345
$14.85
Q 32 Bio Inc Stock (QTTB) Company Profile
명칭
Q 32 Bio Inc
전화
781-999-0232
주소
830 WINTER STREET, WALTHAM
Compare QTTB vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
QTTB
Q 32 Bio Inc
|
12.91 | 218.06M | 53.74M | 33.24M | -27.40M | 2.6632 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Q 32 Bio Inc Stock (QTTB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-25 | 개시 | H.C. Wainwright | Buy |
| 2025-02-11 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2025-02-11 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-12-11 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-12-11 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-12-11 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2024-12-11 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | 개시 | BMO Capital Markets | Outperform |
| 2024-10-24 | 개시 | Raymond James | Strong Buy |
| 2024-09-11 | 개시 | Wells Fargo | Overweight |
| 2024-06-17 | 개시 | Guggenheim | Buy |
| 2024-05-21 | 개시 | Leerink Partners | Outperform |
| 2024-04-11 | 개시 | Oppenheimer | Outperform |
| 2024-04-02 | 개시 | Piper Sandler | Overweight |
| 2023-07-28 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2022-02-22 | 재확인 | BTIG Research | Neutral |
| 2022-02-22 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-02-22 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-03-02 | 개시 | Stifel | Hold |
| 2020-12-14 | 재개 | H.C. Wainwright | Buy |
| 2020-08-11 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-25 | 재개 | BofA/Merrill | Buy |
| 2020-05-13 | 개시 | RBC Capital Mkts | Outperform |
| 2020-03-16 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2020-02-24 | 개시 | Chardan Capital Markets | Buy |
| 2019-11-01 | 개시 | Oppenheimer | Perform |
| 2019-09-10 | 개시 | Robert W. Baird | Outperform |
| 2019-04-12 | 개시 | Evercore ISI | Outperform |
모두보기
Q 32 Bio Inc 주식(QTTB)의 최신 뉴스
QTTB News | Q32 BIO INC (NASDAQ:QTTB) - ChartMill
Atlas Venture fund discloses 625,000 Q32 Bio (QTTB) common shares held - Stock Titan
Q32 Bio Raises $55 Million in Private Placement - Global Legal Chronicle
ORBIMED ADVISORS LLC's Strategic Acquisition in Q32 Bio Inc - GuruFocus
Biotechnology Value Fund (QTTB) group reports 2.37M-share position, 150k warrants - Stock Titan
RA Capital affiliates disclose 2.33M-share stake in Q32 Bio (QTTB) - Stock Titan
Q32 Bio Inc. (QTTB) Tumbles 7% as Shares Nears Key Support ZoneContinuation Pattern Picks - newsline.com
Q32 Bio Inc. Stock (QTTB) Opinions on Massive Price Surge - Moomoo
Monday’s insider activity: Q32 Bio and Outlook see major buys By Investing.com - Investing.com South Africa
Monday’s insider activity: Q32 Bio and Outlook see major buys - Investing.com
OrbiMed entities acquire $15m in Q32 Bio stock - Investing.com
OrbiMed-backed funds add 1.88M Q32 Bio (QTTB) shares in private placement - Stock Titan
Q32 Bio director Xu Diyong buys $15m common stock - Investing.com
OrbiMed boosts Q32 Bio (QTTB) ownership to 17.4% after May 2026 PIPE - Stock Titan
Q32 Bio Company Profile & Introduction - Moomoo
Q32 Bio Inc. Common Stock (QTTB) Stock Price Today & Analysis - Gotrade
Why Is Q32 Bio Stock Gaining Friday? - Benzinga
QTTB Stock Chart | Q32 BIO INC (NASDAQ:QTTB) - ChartMill
Atlas Venture funds (QTTB) join Q32 Bio $5M PIPE deal - Stock Titan
Q32 Bio, Inc. Hits New 52-Week High of $13.15 - MarketsMojo
Q32 Bio: "Buy" On Bempikibart Advancement And Mid-2026 Data Catalysts (NASDAQ:QTTB) - Seeking Alpha
Q32 Bio (QTTB) Is Up 126.6% After US$55M Private Placement With Top Healthcare FundsHas The Bull Case Changed? - simplywall.st
Q32 Bio announces $55M private placement - MSN
Q32 Bio (NASDAQ: QTTB) prices $55M stock and pre-funded warrant sale - Stock Titan
Q32 Bio Inc. (QTTB) Stock: Surges After $55 Million Private Placement Led by Top Biotech Investors - parameter.io
Q32 Bio Inc. (QTTB) Secures $55M in Private Placement of Common Stock - GuruFocus
Q32 Bio Secures $55 Million Private Placement to Advance Alopecia Areata Pipeline (QTTB) - Yahoo Finance
Q32 Bio Inc. announced that it expects to receive $53.8 million in funding from Atlas Venture Advisors, Inc., OrbiMed Advisors LLC, BVF Partners L.P., RA Capital Management, L.P. - marketscreener.com
Q32 Bio announces $55 million private placement financing - marketscreener.com
Q32 Bio Announces $55 Million Private Placement Financing - PR Newswire
Q32 Bio Inc. (QTTB) Surges 81% on Heavy Volume: Key Levels to WatchGEX Level - newsline.com
QTTB - Finviz
Wall Street Analysts Think Q32 Bio (QTTB) Could Surge 145.69%: Read This Before Placing a Bet - Yahoo Finance
Q32 Bio Q1 2026 Earnings: Narrowed Loss Exceeds Expectations, Stock RisesAdjusted Earnings Analysis - The Legal Advocate
This Q32 Bio analyst begins coverage on a bullish note; here are top 3 initiations for Friday - MSN
This Q32 Bio Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday - Benzinga
Mizuho initiates Q32 Bio stock coverage with Outperform rating - Investing.com UK
QTTB | Q32 Bio Inc. Common Analyst Forecasts - Quiver Quantitative
Mizuho initiates Q32 Bio stock coverage with Outperform rating By Investing.com - Investing.com Australia
Q32 BIO INC. (QTTB) - MSN
Q32 Bio gears up to report Q1 earnings: What's in the cards? - MSN
Point72 reports 958,768-share (5.7%) stake in Q32 Bio (QTTB) - Stock Titan
Sirenia and Alex Silverstein report 9.9% stake in Q32 Bio (QTTB) - Stock Titan
Q32 Bio (QTTB) Stock Price, News & Analysis - MarketBeat
Number of shareholders of Q32 Bio Inc. – NASDAQ:QTTB - TradingView
Number of shareholders of Q32 Bio Inc. – BOATS:QTTB - TradingView
The organic vs inorganic growth story at Q32 Bio (QTTB) | Q4 2025: EPS Beats ForecastsReal-time Trade Ideas - newser.com
QTTB SEC FilingsQ32 BIO INC 10-K, 10-Q, 8-K Forms - Stock Titan
QTTB Q32 Bio posts massive EPS beat, yet shares dip despite blowout quarter.Working Capital - newser.com
How Q32 Bio (QTTB) guidance shapes future expectations | Q4 2025: Profit SurprisesBest Pick - newser.com
Q 32 Bio Inc (QTTB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Q 32 Bio Inc 주식 (QTTB) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | Director |
May 28 '26 |
Buy |
8.00 |
1,875,000 |
15,000,000 |
3,502,987 |
| Kalowski Lee | CFO and President |
Feb 25 '26 |
Sale |
4.51 |
3,995 |
18,035 |
35,943 |
| Morrison Jodie Pope | CEO |
Feb 25 '26 |
Sale |
4.51 |
9,896 |
44,675 |
89,104 |
| Violette Shelia M. | Chief Scientific Officer |
Feb 25 '26 |
Sale |
4.51 |
2,815 |
12,708 |
55,569 |
| Morrison Jodie Pope | CEO |
Dec 02 '25 |
Sale |
3.46 |
22,506 |
77,871 |
99,000 |
| Kalowski Lee | CFO and President |
Dec 02 '25 |
Sale |
3.46 |
9,072 |
31,395 |
39,938 |
2.60%
0.94%
자본화:
|
볼륨(24시간):